Cancer Research UK

Supports Cancer Research United Kingdom, the country's largest cancer research organization with nationwide disease-focused grants and fellowships.

Cancer Research UK (CRUK) is the UK's largest cancer research charity. Formed in 2002 from the merger of the Imperial Cancer Research Fund and the Cancer Research Campaign, it carries more than a century of inherited research activity and operates as a registered charity based in London. Its work funds scientists, doctors, and nurses across basic, translational, and clinical cancer science.

CRUK's funding portfolio is built around Discovery Research, Early Detection and Diagnosis, Prevention and Population, and Clinical Research, with Cancer Research Horizons handling translational and commercial work. The live schemes in the record include Discovery Programme Award, Discovery Programme Foundation Award, Therapeutic Catalyst, Senior Cancer Research Fellowship, Early Detection and Diagnosis Programme Award, and Biology to Prevention Award. Award caps span £250,000 to £2.5 million, while the charity's AMRC membership keeps grants to direct costs rather than full economic cost overheads.

That structure suits teams that can connect scientific discovery to biomarkers, screening, prevention, drug development, or clinical studies. Cancer Research Horizons gives CRUK a commercialisation arm with real operating history, including marketed drugs, royalty income, and start-up creation, so applicants are often judged on translational maturity as much as scientific quality. For UK cancer researchers, the council remains a large, selective route with clear thematic lanes and a strong emphasis on impact.